Long-Term Outcome of Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sézary Syndrome: A European Society for Blood and Marrow Transplantation Lymphoma Working Party Extended Analysis
Rafael F. Duarte(Institut Català d'Oncologia), Peter Dreger(Heidelberg University), Norbert Schmitz(University Hospital Münster), Xavier Poiré(Universität Hamburg), Eduardo Olavarría(Universidad de Navarra), William Arcese(University of Rome Tor Vergata), Francesco Onida(Peter MacCallum Cancer Centre), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Franco Narni(Azienda Ospedaliero-Universitaria di Modena), Reyes Arranz, Guido Kobbe(Düsseldorf University Hospital), Ian Gabriel(Imperial College London), Ariane Boumendil(Inserm)
Cited by 91
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k